Life Science Technical Accounting Update on September 16-17, 2025 in San Francisco, United States

From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You'll hear from experts at Deloitte, Ernst and Young, Effectus Group, life science analysts and your industry counterparts.

LEARNING OBJECTIVES:

Understand the latest accounting changes in key areas

Recognize the timelines and key factors affecting the life science industry

Begin to assess the effects of these standards on your company or clients

REGISTRATION INFORMATION:

Cost: $545 (save $150 off the regular price of $695 if you register by August 15th).

This event will run 8:45-4:55p (Pacific Time) each day.

REGISTER NOW »

Register any one of three ways:

1. Register online using a credit card and click the orange button

2. Register by phone at (610) 789-3110

3. Email your contact info to be invoiced to [email protected]

Edit

Agenda: DAY 1

8:45 10:10 Recent Accounting Trends in the Life Science Industry

Collaboration Accounting

Grants

Inbound Licenses

Accounting for Financing Arrangements

10:10 10:20 Break

10:20 11:30 Tax Update

Latest legislative developments

Key Tax Proposals

Build Back Better Act Observations

Possible timing and other legislative priorities

11:30 12:15 Lunch Break

12:15 1:35 Revenue Recognition: Evolving Issues - Life Sciences

Scope of Contract

Performance Obligations

Nature of promise: sales of points

Collaboration agreements

Sales using third party platforms

Gross vs Net

Counterparty Perspective\

1:35 1:50 Break

1:50 3:15 Regulatory Update

Cybersecurity Risk Management, Strategy Governance and Incident Disclosure

Market Trends

SEC Requirements Explained

The Framework

Disclosure Examples

Financial Accounting Update

FASB Project Update

ASUs

Issues on the horizon

3:15 3:25 Break

3:25 4:45 SOX and Internal Controls Update

Risk Assesment

Management Review Controls

Information Used in Controls

IT - General Controls Considerations

Edit

Agenda: DAY 2

8:45 10:00 GenAI Use Cases in Accounting and Finance

Examine risks and myths

Explore AI use cases

Define steps for adopting AI

Practical use cases for today

Exciting use cases for tomorrow

10:00 10:15 Break

10:15 11:45 Gross to Net

Introduction and Overview

Industry View

Estimation Methodology

Approaching Launch

Key Challenges

SEC Comments

Close and Financial Reporting

GTN Hot Topics Discussion

Inventory Accounting Refresh

11:45 12:20 Lunch Break

12:20 1:40 Financing Trends

Royalty Monetization

Convertible Debt

Accounting Considerations

When should companies consider convertible debt?

Convertible structure in the life science financing cycle

Changes of control, tax implications, size, maturity and other questions

1:40 1:50 Break

1:50 3:10 Accounting for R and D and Clinical Trials

R and D Funding Arrangements

R and D Cost Classifications

Other Intangible Assets

SEC Comment Letter Trends

3:10 3:20 Break

3:20 4:40 ESG

ESG Landscape: Regulatory Developments

Operationalizing ESG and Sustainability

Disclosure Trends in Life Sciences Industry

Taking Action

 

URL:

Booking: https://go.evvnt.com/2927789-0?pid=10008

 

Category: Conferences | Business and Economics | Accounting

 

Date and Time: 16th September 2025 at 8:45 am to 17th September 2025 at 4:45 pm